Bristol-Myers Squibb

BMY

101 Followers
$47.56 -4.99% -$2.50
25 July
Upcoming Earnings
 
Market Cap.
 
P/E
Loading...

BMY Fair Price

$19.40
Undervalued by 12.2%
To display the fair price of a share, you need to be a member of Bulios Black.

My Notes

Začít psát

Profile

Bristol-Myers Squibb Company (BMY) is an American pharmaceutical company with a global reach. The company specializes in research, development, and manufacturing of drugs and biological products for the treatment of various diseases. Bristol-Myers Squibb focuses its efforts on the treatment of cancer, cardiovascular diseases, immune disorders, and other serious conditions. The company is known for its innovative medications that bring significant medical benefits to patients. Bristol-Myers Squibb has a wide range of drugs on the market, and its products are distributed worldwide. The company also has an active research program aimed at discovering new drugs and therapeutic approaches. Bristol-Myers Squibb Company (BMY) shares are an attractive choice for investors who follow the pharmaceutical sector and seek investment opportunities in a renowned pharmaceutical company with a focus on innovative treatment methods.

Feed

Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade